Form 8-K - Current report:
SEC Accession No. 0001104659-25-010580
Filing Date
2025-02-07
Accepted
2025-02-07 16:30:33
Documents
15
Period of Report
2025-02-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm255838d1_8k.htm   iXBRL 8-K 34225
2 EXHIBIT 10.1 tm255838d1_ex10-1.htm EX-10.1 76127
3 EXHIBIT 10.2 tm255838d1_ex10-2.htm EX-10.2 15469
  Complete submission text file 0001104659-25-010580.txt   328948

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tmb-20250205.xsd EX-101.SCH 3012
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tmb-20250205_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tmb-20250205_pre.xml EX-101.PRE 22358
17 EXTRACTED XBRL INSTANCE DOCUMENT tm255838d1_8k_htm.xml XML 3597
Mailing Address 12 PENNS TRAIL NEWTOWN PA 18940
Business Address 12 PENNS TRAIL NEWTOWN PA 18940 267-759-3680
Traws Pharma, Inc. (Filer) CIK: 0001130598 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36020 | Film No.: 25602334
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)